Navigation Links
Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
Date:10/6/2008

MOUNTAIN VIEW, Calif. and SEATTLE, Oct. 6 /PRNewswire/ -- Complete Genomics Inc., a newly launched, third-generation human genome sequencing company, and the Institute for Systems Biology (ISB) today announced their partnership to conduct populationwide human genome studies.

In phase one of the project, Complete Genomics will use its proprietary DNA sequencing technology to sequence five genomes from samples provided by ISB. Then, once proof-of-concept has been demonstrated, ISB and Complete Genomics plan to expand this collaboration to sequence the genomes of 100 individuals in 2009 and 2,000 individuals in 2010.

"Using Complete Genomics' human genome sequencing services to gather populationwide human genetic data will allow us to gain a more complete understanding of the genetic components and molecular processes of diseases in order to better manage, treat and prevent human disease and better understand human health," said Dr. Leroy Hood, president of ISB and member of Complete Genomics' Scientific Advisory Board.

"This collaboration demonstrates the value of our sequencing service business model and underscores our vision of using our large-scale, low-cost DNA sequencing technology to elucidate disease pathways," said Dr. Clifford Reid, chairman, president and CEO of Complete Genomics. "We are pleased to be partnering with such a renowned organization as the Institute for Systems Biology on a project that will provide the data that researchers need to develop better drugs, therapeutics and diagnostics."

About Complete Genomics

Founded in 2006, Complete Genomics is a California company that has developed a novel approach to sequencing human DNA. Complete Genomics plans to combine its proprietary third-generation DNA sequencing technology and its high-performance computing capabilities to create a human genome sequencing service that will deliver low-cost, high-quality data on an unprecedented scale. The company is currently building the world's largest human genome sequencing center. This development will allow pharmaceutical and biotechnology customers, for the first time, to conduct large-scale human genome studies that will help identify the genetic underpinnings of complex diseases and drug responses. For additional information about the company, please visit http://www.completegenomics.com.

About the Institute for Systems Biology

Founded in 2000, the Institute for Systems Biology (ISB) is an internationally renowned, non-profit research institute headquartered in Seattle and dedicated to the study and application of systems biology. ISB seeks to use systems methods to unravel the complexity of human biology and identify strategies for predicting and preventing significant diseases such as cancer, diabetes and AIDS. ISB's systems approach integrates biology, computation and technological development, focusing on entire, complex biological systems rather than one gene or protein at a time. For more information about ISB, visit http://www.systemsbiology.org.


'/>"/>
SOURCE Complete Genomics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Acute Coronary Syndrome (ACS) Trial
2. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
3. Arpida Completes Enrolment in Phase II "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
4. Recruitment Completed in Ofatumumab NHL Pivotal Study
5. Merck Serono Completes Enrollment in the REFLEX Trial of Rebif(R) in Patients at Risk of Developing Multiple Sclerosis
6. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
7. Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III Clinical Trial of Sodium Oxybate to Treat Fibromyalgia
8. CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma
9. DEP to Complete Aerial Mosquito Treatments to Stem West Nile Virus in Southeastern Counties
10. Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
11. Human Genome Sciences Completes Enrollment in Randomized Phase 2 Trial of HGS-ETR1 in Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... their offering. ... The global chromatography market to grow at a ... Market 2016-2020, has been prepared based on an in-depth market analysis with ... growth prospects over the coming years. The report also includes a discussion ...
(Date:12/8/2016)...  Economic growth in the United States will continue ... executives in their December 2016 Semiannual Economic Forecast. Expectations ... began in mid-2009, as indicated in the monthly ISM ... The manufacturing sector is optimistic about growth in 2017, ... and the non-manufacturing sector indicates that 14 of its ...
(Date:12/8/2016)... NEW YORK , Dec. 8, 2016 ... today that it will charge enterprise customers only when ... model disrupts the health and wellness sector, which typically ... Logo - http://photos.prnewswire.com/prnh/20161207/446824LOGO ... platform  combines the power of technology with the empathy ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it had joined the Pharmaceutical ... a non-profit organization to unite pharmaceutical and healthcare companies that share a vision ...
(Date:12/8/2016)... NC (PRWEB) , ... December 08, 2016 , ... ... Medicare and the Affordable Care Act. Dr. Botelho advocates for the mass media ... story movement gives people ongoing opportunities to share their unfortunate experiences; such a ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an Arizona-based ... the greater Phoenix metropolitan region, is announcing a charity event to provide support ... Homeless Youth Connection is to promote community awareness of the ongoing needs of ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated ... it is one of the early adopters completing EU-U.S. Privacy Shield Certification from the ... provide companies on both sides of the Atlantic with a mechanism to comply with ...
(Date:12/7/2016)... New Orleans, LA (PRWEB) , ... December 07, ... ... cosmetic technique used to treat wrinkles and deep lines by smoothing and tightening ... many minimally invasive techniques out there to address facial aging with very little ...
Breaking Medicine News(10 mins):